[HTML][HTML] SETD2: from chromatin modifier to multipronged regulator of the genome and beyond
TM Molenaar, F van Leeuwen - Cellular and Molecular Life Sciences, 2022 - Springer
Histone modifying enzymes play critical roles in many key cellular processes and are
appealing proteins for targeting by small molecules in disease. However, while the functions …
appealing proteins for targeting by small molecules in disease. However, while the functions …
Molecular mechanisms in governing genomic stability and tumor suppression by the SETD2 H3K36 methyltransferase
Epigenetic dysregulation is an important contributor to carcinogenesis. This is not surprising,
as chromatin—genomic DNA organized around structural histone scaffolding—serves as the …
as chromatin—genomic DNA organized around structural histone scaffolding—serves as the …
[HTML][HTML] N6-Methyladenosine methylation regulator RBM15 is a potential prognostic biomarker and promotes cell proliferation in pancreatic adenocarcinoma
Z Zhao, Q Ju, J Ji, Y Li, Y Zhao - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
RNA binding motif protein 15 (RBM15) is a key regulatory factor involved in N6-
methyladenosine (m6A) methylation. It has been reported that RBM15 plays an important …
methyladenosine (m6A) methylation. It has been reported that RBM15 plays an important …
Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101 …
J Liu, Y Shi, Y Zhang - EPMA Journal, 2023 - Springer
Background Clear cell renal cell carcinoma (ccRCC) is a prevalent urological malignancy
associated with a high mortality rate. The lack of a reliable prognostic biomarker undermines …
associated with a high mortality rate. The lack of a reliable prognostic biomarker undermines …
Gene expression profiling identifies two chordoma subtypes associated with distinct molecular mechanisms and clinical outcomes
J Bai, J Shi, Y Zhang, C Li, Y Xiong, H Koka… - Clinical Cancer …, 2023 - AACR
Purpose: Chordoma is a rare bone tumor with a high recurrence rate and limited treatment
options. The aim of this study was to identify molecular subtypes of chordoma that may …
options. The aim of this study was to identify molecular subtypes of chordoma that may …
[HTML][HTML] A pan-cancer bioinformatic analysis of RAD51 regarding the values for diagnosis, prognosis, and therapeutic prediction
H Liu, J Weng - Frontiers in oncology, 2022 - frontiersin.org
Background RAD51, a critical protein for DNA repairment, has been found to associate with
multiple cancer types, but, so far, a systematic pan-cancer analysis of RAD51 has not been …
multiple cancer types, but, so far, a systematic pan-cancer analysis of RAD51 has not been …
[HTML][HTML] Multi-omics analysis of MCM2 as a promising biomarker in pan-cancer
J Yuan, H Lan, D Huang, X Guo, C Liu, S Liu… - Frontiers in cell and …, 2022 - frontiersin.org
Minichromosome maintenance 2 (MCM2) is a member of the minichromosomal
maintenance family of proteins that mainly regulates DNA replication and the cell cycle and …
maintenance family of proteins that mainly regulates DNA replication and the cell cycle and …
Alternative complement pathway signature determines immunosuppression and resistance to immunotherapy plus tyrosine kinase inhibitor combinations in renal cell …
J Wang, S Zhang, Y Wang, Y Zhu, X Xu… - … Oncology: Seminars and …, 2023 - Elsevier
Background Latest guidelines recommended immunotherapy (IO) plus tyrosine kinase
inhibitor (TKI) combination as standard first-line therapy in renal cell carcinoma (RCC), with …
inhibitor (TKI) combination as standard first-line therapy in renal cell carcinoma (RCC), with …
[HTML][HTML] Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types
Abstract Background Solute Carrier Family 31 Member 1 (SLC31A1) has recently been
identified as a cuproptosis-regulatory gene. Recent studies have indicated that SLC31A1 …
identified as a cuproptosis-regulatory gene. Recent studies have indicated that SLC31A1 …
[HTML][HTML] SETD2-H3K36ME3: an important bridge between the environment and tumors
J He, T Xu, F Zhao, J Guo, Q Hu - Frontiers in Genetics, 2023 - frontiersin.org
Epigenetic regulation plays an important role in the occurrence, development and treatment
of tumors. The histone methyltransferase SET-domain-containing 2 (SETD2) plays a key role …
of tumors. The histone methyltransferase SET-domain-containing 2 (SETD2) plays a key role …